Jefferies has initiated coverage on Sai Life Sciences with a 'Buy' rating and a Rs 1,300 target price, citing its integrated 'follow-the-molecule' model and strong growth outlook. The brokerage ...

Discover expert strategies to simplify long distance business relocations, reduce costs, and avoid disruptions.

Bank of America’s price target remains unchanged, with no shift from prior estimates. Even without an adjustment to the target level, you can still learn a lot by watching how the story around the ...

What’s Changed? On Feb. 20, Steel Dynamics’ board declared a first-quarter 2026 dividend of $0.53 per share, up from the prior year’s $0.50.

Most finance leaders track headcount costs meticulously but miss the depreciation expense hiding in plain sight: workforce ...

Alphabet stock has beaten the S&P 500, topped Q4 revenue/EPS estimates, and holds massive net cash. See its fair value and ...

A company can look well placed for the EV transformation on paper and still leave important questions unanswered in the ...

Duquesne Family Office’s Q4 2025 13F: top holdings, new stakes, big adds/cuts, and exits in Amazon, Alphabet, Natera & ...

Maximizing credit card rewards doesn't have to be complicated. Here's the surprisingly lazy system that works for most people.

Here are three stocks across a range of risk levels with attractive growth histories and prospects.

With Lumentum’s (NASDAQ: LITE) inclusion in S&P 500 effective March 23, 2026, passive index funds face a date-certain obligation to buy shares regardless of valuation. The question is how the ...

Oracle (NYSE:ORCL) reported its fiscal third-quarter 2026 results after the bell on Tuesday, March 10, and the market liked what it saw. ORCL stock rose approximately 9% in premarket trading on ...